Healthtech Startups

VCA Animal Hospitals operates a national network of veterinary hospitals providing primary care, specialty care, emergency care, urgent care, and boarding services for pets. The company combines advanced medical technology and procedures with compassionate care for pet owners and their animals.

1 investor

VC Gene Therapy develops gene therapies, with a first pipeline using genome editing to treat autosomal dominant inherited retinal degenerative diseases and aiming to begin clinical trials. It is a subsidiary of Vision Care Inc. and part of the Vision Care Group, based in Kobe, Japan.

1 investor

VEA builds AI-based software for veterinary practices, including diagnostic tools and practice management workflows. It serves veterinary professionals and teams in the pet care industry.

1 investor

Veba is a device that monitors and tracks breast milk and formula through automated temperature, time, and feeding tracking, sending expiration alerts to parents and caregivers.

1 investor

Vectech develops AI-powered vector identification and surveillance technologies to support public health interventions and targeted mosquito control during disease outbreaks. The company serves public health organizations and disease prevention agencies globally.

1 investor

Vector Biomed develops lentiviral vectors for cell and gene therapy, focusing on affordable, scalable vector solutions with transparent pricing and no hidden royalties. It positions itself as a manufacturing and development partner for researchers and therapeutic developers.

1 investor

Vedi is a vet-tech company providing electronic health records for veterinary care, linking an animal's medical information to their microchip so records follow the pet across clinics, labs, shelters and owners. It serves veterinarians, clinics and pet owners, and connects to labs and microchip registries to reduce admin and data-entry errors.

1 investor

Vee Healthtek provides revenue cycle management and AI-driven automation solutions for healthcare providers and payers. The company helps healthcare organizations optimize financial performance and operational efficiency through intelligent automation and data-driven innovation.

1 investor

VeeOne Health offers healthcare revenue cycle management services aimed at helping hospitals and clinics get paid for the care they provide. It serves providers ranging from large regional hospitals to neighborhood clinics.

1 investor

Vega Health helps health systems evaluate, implement, monitor, and scale third-party AI solutions across their organizations, focusing on last-mile implementation and objective performance monitoring. It serves healthcare delivery organizations, acting as a vendor-neutral partner sourcing validated clinical and operational AI tools.

1 investor

Vega Surgical develops neurosurgical devices, including the XCAPE cranial port and XPD access system, for cranial access and controlled fluid evacuation in treating chronic subdural hematomas (CSDH). The Colorado-based company's products are designed for neurosurgeons and hospitals to improve patient outcomes and procedure efficiency.

1 investor

VEGAIN produces plant-based sports nutrition products designed for athletic performance and fitness, positioning themselves as a sustainable alternative to animal-based options. The company is Canadian-based and emphasizes clean formulations, scientific backing, and environmental responsibility.

1 investor

VeinCentre is a UK medical provider specialising in the diagnosis and treatment of varicose veins, venous leg ulcers, and facial thread veins using minimally invasive, walk-in walk-out procedures. Operating over 40 clinics nationwide, it serves patients seeking vein care and is the country's largest dedicated vein specialist.

1 investor

Veirulence develops first-in-class non-antibiotic small molecule therapeutics that target bacterial virulence factors to treat resistant infections, with an initial focus on the WHO priority pathogen Pseudomonas aeruginosa. The company aims to address antimicrobial resistance in hospital-acquired bacterial infections.

1 investor

Vektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias. Its technology targets electrophysiologists and cardiologists working in cardiac rhythm management.

1 investor

Velentium Medical is an engineering services partner that develops medical devices from early concept through manufacturing, covering Class II wearables to Class III implantables. It integrates product development, cybersecurity, manufacturing, and test systems to serve medical device companies facing technical and regulatory challenges.

1 investor

Velico is a clinical-stage medical technology company developing a spray-dried "dry plasma" manufacturing system that enables blood centers to produce point-of-care plasma products for transfusion. Its products are aimed at pre-hospital, military, ambulance, and mass-casualty settings to reduce preventable death from bleeding.

1 investor

1 investor

WCG eResearch Enterprise CTMS is a clinical trial management system that automates administrative, financial, and research activities for research sites including academic medical centers, hospitals, and health systems. The platform provides integrated operations, financial oversight, participant management, and reporting to help sites manage clinical trials efficiently from initiation through close-out.

1 investor

Veloxis Pharmaceuticals is a specialty pharmaceutical company that develops therapies and programs for the prevention of organ rejection in transplant patients, serving transplant healthcare providers and the patients they treat. It is part of Asahi Kasei Corporation and is advancing investigational immunosuppressive agents for kidney and heart transplant recipients.

1 investor

veMico develops postbiotics — bioactive compounds derived from probiotic bacteria — that act on the host's immune system and gut barrier to improve gut health. It offers product development, bioactive licensing, and research collaboration for partners in the gut health and nutrition space.

1 investor

1 investor

Venock is developing a percutaneous handheld vascular closure device that automatically seals large-bore punctures in the femoral vein within 1-2 minutes following interventional procedures. It targets interventional cardiologists, hospitals, and cathlabs performing trans-venous therapies such as structural heart interventions in the USA and Europe.

1 investor

Venous Stent develops ALTA®, a modular stent designed to treat deep venous disease in the iliac and femoral veins. The company combines clinical expertise with engineering to create anatomy-adaptive solutions for physicians treating complex venous conditions.

1 investor